31 Oct TomoTherapy's 100th radiology system reaches public sector
Madison, Wis. – TomoTherapy, Inc. has reached the public sector with the sale of its 100th Hi-Art radiology system.
The Stratton VA Medical Center in Albany, N.Y., a hospital under the U.S. Department of Veterans Affairs, now is treating patients with TomoTherapy’s cancer-targeting system, the company announced.
The TomoTherapy Hi-Art System combines CT imaging with what the company calls conformal radiation therapy that targets tumors while limiting damage to surrounding tissues. Researchers from the University of Wisconsin-Madison developed the technology.
“Our nation’s heroes deserve state-of-the-art cancer care,” Dr. Ralf Kiehl, radiation oncologist at Stratton, said in a release. “The technology is amazing, and may result in not only more precisely targeted doses, but may ultimately lessen overall treatment time.”
Kiehl said he plans to treat veterans with prostate cancer, head and neck injuries, lung and brain tumors, and other conditions. The system will not only improve treatments, but enable the center to perform more of them, Kiehl said.
“The average time for delivery of a conventional linear accelerator treatment ranges from 15 to 30 minutes,” Kiehl said. The system “requires minimal targeting time, and the entire process typically takes five to 10 minutes less than conventional treatment.”
The center serves veterans within a 100-mile radius of Albany, including 22 counties in upstate New York.
• TomoTherapy: A Marriage of IT and Biotech
• TomoTherapy leads the industry in CT image-guided treatments
• City of Hope adds second TomoTherapy system
• TomoTherapy extends reach to Germany